Emmanuel Papadakis analyst DEUTSCHE BANK

Currently out of the existing stock ratings of Emmanuel Papadakis, 33 are a SELL (21.02%), 64 are a HOLD (40.76%), 60 are a BUY (38.22%).

Emmanuel Papadakis

Work Performance Price Targets & Ratings Chart

Analyst Emmanuel Papadakis, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 66.76% that have a potential upside of 27.81% achieved within 231 days. Previously, Emmanuel Papadakis worked at UBS, BARCLAYS, LEERINK.

Emmanuel Papadakis’s has documented 232 price targets and ratings displayed on 20 stocks. The coverage is on Healthcare, Basic Materials, Consumer Defensive, Consumer Cyclical sectors.

Most recent stock forecast was given on ARGX, argenx NV ADR at 12-Sep-2025.

Wall Street Analyst Emmanuel Papadakis

Analyst best performing recommendations are on ALVO (ALVOTECH).
The best stock recommendation documented was for ALVO (ALVOTECH) at 11/25/2022. The price target of $8 was fulfilled within 13 days with a profit of $1.95 (32.23%) receiving and performance score of 24.79.

Average potential price target upside

AZN AstraZeneca PLC ADR GLPG Galapagos NV ADR GRFS Grifols SA ADR GSK GlaxoSmithKline PLC ADR MRNA Moderna NVO Novo Nordisk A/S NVS Novartis AG ADR SNY Sanofi ADR ARGX argenx NV ADR GMAB Genmab AS MOR MorphoSys AG ADR ALVO Alvotech LBTSF Almirall RHHBY Roche Holding Ltd ADR BNTX BioNTech SE CVAC CureVac NV HL Hecla Mining Company LB L Brands MO Altria Group RH RH

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Dec-2019

$105

$-83.41 (-44.27%)

$95

Buy Since 05-Sep-2023

$108.5

$-79.91 (-42.41%)

$91.7

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Emmanuel Papadakis?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?